Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Beyond Meat (BYND) Set to Open Up 3.9% Following Upgrade
-
European factories at risk in Peugeot-Fiat merger
-
Change Capital Appoints Scott Bernstein as General Counsel
-
Aramco share sale curb rules out overseas listing for at least a year
-
Orsted A/S (ORSTED:DC) (DNNGY) PT Lowered to DKK595 at Bernstein
-
Bernstein Upgrades Beyond Meat (BYND) to Outperform on Expected Sales Growth Potential
-
The Hartford Announces Third Quarter 2019 Net Income Available To Common Stockholders Of $1.43 Per Diluted Share And Core Earnings Of $1.50 Per Diluted Share
-
BA parent IAG ups bet on Latin America with Air Europa takeover
-
How one county scrambled to keep America measles-free
-
Give or take a trillion: Investors still in the dark on Saudi Aramco value
-
CapitalOne Upgrades New Senior (SNR) to Overweight
-
Tiffany (TIF) Board Meets on LVHM Offer - Rumor
-
AMD Announces Upcoming Investment Community Events
-
AMD Announces Upcoming Investment Community Events
-
Shell under fire over buyback delay warning
-
Kraft Heinz beats profit estimates, plans to boost marketing; shares surge
-
Apple (AAPL) May Not be Off to the Races, PT Raised to $250 at Bernstein
-
Cigna raises 2019 forecast as Express Scripts buyout pays off
-
Bernstein Downgrades Southwest (LUV) to Market Perform
-
China's state telecoms to launch 5G services on Friday
-
Seth P. Bernstein, President and CEO, to Participate in the 2019 Bank of America Merrill Lynch Future of Financials Conference on November 6
-
Hospitals, Third-Party Payors, and People Who Bought or Provided Reimbursement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin, Could Be Included in a Class Action Lawsuit
-
The Misty II Platform Robot Is Now Available for Purchase
-
Bernstein Upgrades Biogen (BIIB) to Outperform, Boosts PT on Positive Aducanumab Risk-Reward
-
Bel Reports Third Quarter 2019 Results
-
Tesla (TSLA) Notes Benefit From Commercial Negotiations in 10Q - Bernstein
-
AMD (AMD) Guidance "A Touch Light", Bernstein Reiterates Market Perform
-
Bernstein Downgrades Tiffany & Co. (TIF) to Market Perform Following Proposed Takeover
-
Airbus cuts delivery goal on Hamburg plant snags
-
Micron Technology Announces Upcoming Investor Event
-
Micron Technology Announces Upcoming Investor Event
-
Weber Shandwick Bolsters Its North America Network With New Leaders in New York and Boston
-
Silicon Valley Forum’s 22nd Annual Visionaries Are Announced!
-
Bernstein Downgrades Tiffany & Co. (TIF) to Market Perform
-
Bernstein Downgrades Bharti Airtel Ltd (BHARTI:IN) to Market Perform
-
Bernstein Downgrades Vodafone Idea Ltd. (IDEA:IN) to Underperform
-
nLIGHT Announces Dates for Upcoming Investor Conference Participation
-
nLIGHT Announces Dates for Upcoming Investor Conference Participation
-
VW ramps up China electric car factories, taking aim at Tesla
-
Wilson College Appoints Dr. Wesley R. Fugate as Next President
-
HiFiBiO Therapeutics Establishes World-Class Scientific Advisory Board
-
Beyond Meat Inc. (BYND) PT Lowered to $100 at Bernstein
-
CapitalOne Downgrades Ventas (VTR) to Equal-weight
-
Cadence’s Nimish Modi to Present at 6th Annual Bernstein Technology Innovation Summit in New York, NY
-
Form 4 Retail Value Inc. For: Oct 23 Filed by: Otto-Bernstein Katharina
-
Buy Johnson & Johnson (JNJ) on Baby Powder Weakness - Bernstein
-
Raytheon (RTN) PT Raised to $225 at Bernstein
-
Northrop Grumman (NOC) PT Raised to $385 at Bernstein
-
Melissa & Doug Get Well Doctor Activity Center Honored With Good Housekeeping's 2019 Best Toy Award
-
Factbox: Trump, Democrats at South Carolina forum on criminal justice reforms

